SmartStart Health: Unlocking life-changing benefits of CGM in diabetes
DCB and SmartStart Health collaborate to develop and validate a world-first patient education mobile app to increase knowledge and improve outcomes among people with diabetes using continuous glucose monitoring (CGM).
Overwhelming amount of CGM data
When people with diabetes/caregivers start using CGM to gain tighter diabetes control, they face a steep learning curve, regardless of how many years they have lived with diabetes. They’re overwhelmed by hundreds of data points per day, trend arrows and fine-tuning settings for alerts and alarms. They are aware that CGM can be a powerful tool for minimising high and low blood glucose levels and improving their quality of life, but they aren’t sure how to achieve these outcomes. Without timely support to use CGM effectively, people with diabetes/caregivers may see CGM data as clear documentation of diabetes management challenges they feel they cannot overcome.
SmartStart CGM as an innovative solution for CGM education
Education is important for people using CGM to be able to understand and use CGM data to make appropriate treatment decisions that lead to quality of life benefits as well as improvements in diabetes outcomes. SmartStart Health is rising to the challenge of CGM-specific patient education with SmartStart CGM, a user-friendly smartphone app. Supported by DCB, diabetes centres in the US and Switzerland will evaluate the new scalable solution in a proof-of-concept study. The partnership aims to analyse the results in Q3 2022 and publish by mid-2023.
The SmartStart CGM app is designed to inform and empower users with interactive micro-learning based on real-world scenarios that reflect the reality of living with diabetes. A telehealth portal for healthcare professionals will enable clinicians to assess patient engagement with the programme.
Project team: Melissa Holloway (Founder & CEO), Kieron Heath (Operations), Effra Digital (Technology consultant), Will Hargreaves (Business development), Jamie Welsh (Content development)
Funding: DCB supports SmartStart Health with 100k CHF funding
Melissa Holloway, CEO and Founder of SmartStart Health
Links
More recent projects
Menstrual Cycle Study: Identifying changes in insulin sensitivity across the menstrual cycle in T1D
DCB and Tidepool are entering a partnership to explore the relationship between diabetes and women’s health. The first...
enhance-d: Enhanced Diabetes Self-Management
Diabetes technology generates a lot of data, but rarely is all this data used to inform action. DCB supports enhance-d...
Qarbs: Accurate results for estimating carbohydrates
Estimating carbohydrates as supreme discipline for people living with diabetes is still depending on gut feelings and...
DCB Research AG
Freiburgstrasse 3
3010 Bern
Switzerland